Review Article
Published in:
Volume 2 / Year 2013 / Issue 3
Volume 2 / Year 2013 / Issue 3
Safety and toxicity of biosimilars—EU versus US regulation
Author(s): 1 Tobias Blank, PhD, Angela Vogt-Eisele, PhD, Professor Marietta Kaszkin-Bettag, PhD, Tilo Netzer, PhD, Wolfram Hildebrandt, MSc, MA
Page: 144-50
Page: 144-50
Author byline as per print journal: Tobias Blank, PhD, Tilo Netzer, PhD, Wolfram Hildebrandt, MSc, MA, Angela Vogt-Eisele, PhD, Professor Marietta Kaszkin-Bettag, PhD Background: As patents for biological drugs begin… Read More »
Steps to ensure adequate supply of biological medicines: considerations for the healthcare provider
Author byline as per print journal: Andrew Mica, MBA, Martha Mutomba, PhD, Larry Green, PharmD Introduction: When drug shortages occur, healthcare providers (HCPs) often must ration drugs, cancel or delay… Read More »